Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) [Phase 2]

View source ↗

Summary

The document reports the completed Phase 2 study assessing the safety and efficacy of an investigational drug in HIV-infected patients, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Investigational drug (NCT00100048)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-03-29